Puissance Capital Management L.P. 13F annual report

Puissance Capital Management L.P. is an investment fund managing more than $23.4 million ran by Axel Jin. There are currently 4 companies in Mr. Jin’s portfolio. The largest investments include Bellerophon Therapeutics and Ekso Bionics, together worth $21 million.

$23.4 million Assets Under Management (AUM)

As of 7th October 2020, Puissance Capital Management L.P.’s top holding is 1,153,846 shares of Bellerophon Therapeutics currently worth over $14.5 million and making up 61.8% of the portfolio value. Relative to the number of outstanding shares of Bellerophon Therapeutics, Puissance Capital Management L.P. owns more than 0.1% of the company. In addition, the fund holds 774,400 shares of Ekso Bionics worth $6.51 million, whose value grew 39.7% in the past six months. The third-largest holding is SCYNEXIS worth $2.34 million and the next is Corvus Pharmaceuticals worth $103 thousand, with 38,010 shares owned.

Currently, Puissance Capital Management L.P.'s portfolio is worth at least $23.4 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Puissance Capital Management L.P.

The Puissance Capital Management L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Axel Jin serves as the CFO at Puissance Capital Management L.P..

Recent trades

In the most recent 13F filing, Puissance Capital Management L.P. revealed that it had increased its stake in Bellerophon Therapeutics and bought 600,596 additional shares worth around $6 million. This means they effectively own 0.1% of the company. Bellerophon Therapeutics makes up 61.8% of the fund's Health Care sector allocation and has grown its share price by 1968.1% in the past year.

On the other hand, there are companies that Puissance Capital Management L.P. is getting rid of from its portfolio. Puissance Capital Management L.P. closed its position in Kadmon on 13th August 2020. It sold the previously owned 30,000 shares for $126 thousand.

One of the smallest hedge funds

The two most similar investment funds to Puissance Capital Management L.P. are Alpine Usvi and Crabel Capital Management. They manage $23.4 million and $23.3 million respectively.

Axel Jin investment strategy

Puissance Capital Management L.P.’s portfolio is diversified across 1 sector. Currently, their heaviest sector is Health Care — making up 100.0% of the total portfolio value. The fund focuses on investments in the United States as 100.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are small-cap stocks. Stocks with a size of more than $100 million in market cap make up 75% of the total holdings value. On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $69.8 million.

The complete list of Puissance Capital Management L.P. trades based on 13F SEC filings

These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Bellerophon Therapeutics, Inc.	108.56% 1,153,846	$14,481,000	61.82%
Ekso Bionics Holdings, Inc.	No change 774,400	$6,505,000	27.77%
SCYNEXIS, Inc.	3,514.80% 3,111,436	$2,336,000	9.97%
Kadmon Holdings, Inc.	Closed 30,000	$126,000
Corvus Pharmaceuticals, Inc.	No change 38,010	$103,000	0.44%
TRACON Pharmaceuticals, Inc.	Closed 18,107	$31,000
No transactions found
Showing first 500 out of 6 holdings